Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

45 results about "Baby Formulas" patented technology

Fluorescent Chemical Sensor Array for Detecting Infant Formula and Method for Detecting Infant Formula Using the Same

The present invention provides a fluorescent chemical sensor array for detecting infant formula milk powder and a method for detecting infant formula milk powder using the same. The fluorescent chemical sensor array includes the following sensor units: a first sensor unit, which is a compound having the structure shown in Formula I (i.e., PPE2); a second sensor unit, which is a compound having the structure shown in Formula II (i.e., PPE-SO3); and a third sensor unit, which is a compound having the structure shown in Formula III (i.e., PPE-N1). In Formula I, Formula II, and Formula III, n is independently 9-60. The present invention can use the fluorescent chemical sensor array and the LDA pattern recognition algorithm to detect and distinguish different types, different origins, and different brands of infant formula milk powder, and can optimize the sensor array to achieve the purpose of differentiating detection with the least number of sensing units.
Owner:TSINGHUA SHENZHEN INTERNATIONAL GRADUATE SCHOOL

Infant formula for improving cognitive development

A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of lipid globules which are at least partly coated on the surface with phospholipids, for increasing myelination in the brain of an infant who has delayed brain development or is at risk of having delayed brain development.
Owner:NV NUTRICIA

A composition for improving asthenopia and use thereof

The application discloses a composition for improving asthenopia and application, and the composition is compounded by longissimum bifidobacterium longum subsp i772, 2'-fucose lactose, lacto-N-neotetraose and lutein with a weight ratio of 1-100:460-1600:120-400:0.03-0.35. The composition for improving asthenopia has a synergistic effect in the function of relieving asthenopia, longissimum bifidobacterium longum subsp i772, 2'-fucose lactose, lacto-N-neotetraose and lutein can effectively relieve the apoptosis of eye cells caused by asthenopia, and the composition can be applied to infant formula milk powder, children's formula milk powder, fermented milk and health food.
Owner:JUNLEBAO DAIRY GRP CO LTD +1

Protein compositions with high isoelectric proteins

The present invention is in the field of protein compositions, in particular protein compositions for infant milk formula. The protein compositions according to the invention comprise whey protein, casein and high isoelectric point proteins, such as those having an isoelectric point of at least 6.0. The present invention further relates to the uses of the protein compositions.
Owner:NV NUTRICIA

Method of making infant formula and related devices

An infant formula cartridge for preparing infant formula from premeasured quantities of dry or concentrated liquid components. The cartridge includes a base portion defining a vessel adapted to be received in a seated relation in a concentrate-introduction chamber, a cover portion sealably joined to an opening of the base portion, the base portion and the cover portion cooperating to define an inner containment space, and an inner casing disposed within the inner containment space of the base portion and containing powdered infant formula concentrate, wherein an interior of the inner casing is in fluid communication with an exterior of the inner casing.
Owner:SIMS BRIAN

Method for predicting micro-contextual risk causal relationships of infant formula production sequence polynucleotide sequences

The application provides a method for predicting the micro-scene risk causal relationship of multiple sequences in an infant formula production sequence, comprising: S1, selecting sequences in process indicators of infant formula, extracting sequence data, forming M different source sequence data as a data set D; S2, performing stationary processing on the sequence data in the data set D, expanding the data set D using a sliding time slice, forming a new data set Data, and the data set Data containing target sequences and variable sequences. The application extracts similar sequence segments and excludes interference sequence segments from the related sequences of raw material indicators, production process parameters and product indicators of infant formula, selects the most relevant sequence segment to the target prediction indicator through causal analysis, establishes a related micro-scene for prediction analysis, mines out the key control points and key process control parameters that have the greatest impact on the quality of the infant formula product, and finds out the relatively optimal value.
Owner:BEINMATE (HANGZHOU) FOOD RES INST CO LTD

Infant nutrition containing hydrolyzed protein, ionized calcium and palmitic acid

The present invention relates to a composition for a formula for infants or young children, the composition comprising a partially hydrolyzed protein, ionized calcium and an oil mixture comprising palmitic acid esterified to a triacylglycerol wherein the palmitic acid is esterified at the sn-2 position of the triacylglycerol, the esterified palmitic acid being in an amount of at least 20% by weight of the total palmitic acid. Furthermore, the present invention relates to an infant formula comprising said composition and the use of said composition or infant formula.
Owner:SOCIETE DES PRODUITS NESTLE SA

Bifidobacterium longum subsp. Infantis i18 with effect of regulating intestinal flora and application thereof

PendingCN121950586Arich typemaintain steady stateMilk preparationBacteriaBiotechnologyGut flora
The invention discloses bifidobacterium longum subsp. Infantis i18 with an effect of regulating intestinal flora and application of the bifidobacterium longum subsp. Infantis i18, and belongs to the technical field of microbial engineering. The bifidobacterium longum subsp. Infantis i18 strain is preserved in the China General Microbiological Culture Collection Center, the preservation address is No.3, No.1 yard, Beichen West Road, Chaoyang District, Beijing, the preservation date is July 25, 2024, the preservation number is CGMCC NO.31411, and the Latin name is Bifidobacterium longum subsp. Infantis. The invention also discloses a preparation method of the bifidobacterium longum subsp. Infantis strain. The bifidobacterium longum subsp. Infantis i18 provided by the invention has a bidirectional regulation effect, can relax bowel, relieve diarrhea, maintain intestinal steady state and regulate intestinal flora at the same time, expands the application range of the bifidobacterium longum subsp. Infantis, and enriches the types of the domestic bifidobacterium longum subsp. Infantis. The preparation method is suitable for preparing the probiotic agent or the infant formula milk powder.
Owner:JUNLEBAO DAIRY GRP CO LTD

Product containers and container assemblies

The present disclosure provides containers and container assemblies for storing and dispensing products, such as infant formula, nutritional and fitness supplements, coffee, sugar, flour, dissolvable cannabinoid, edible cannabis, gummies, flowers, buds, candy, chocolates, baked goods and the like. The containers have a measuring and dispensing device, such as a utensil, removably secured to an internal wall of the container to prevent the utensil from becoming buried within the product. The container may be formed from first and second portions that are molded separately from each other and then joined together, allowing it to be manufactured quickly, easily, and inexpensively.
Owner:KENZINC LLC

Lipid rich in sphingomyelin, preparation method and phospholipid ingredient for infant formula milk powder

The invention provides lipid rich in sphingomyelin, a preparation method and a phospholipid ingredient for infant formula milk powder, and relates to the technical field of dairy product processing.The lipid rich in sphingomyelin and the preparation method thereof have the advantages that primary separation is carried out by the aid of supercritical carbon dioxide extraction technologies, secondary extraction is carried out by the aid of follow-up ethyl alcohol serving as entrainer, non-polar lipid can be effectively removed, and the lipid rich in sphingomyelin can be obtained; and phospholipids with high polarity, especially sphingomyelin, are retained. The ethanol concentration is controlled to be 20% (v / v), so that the solubility and the selective extraction efficiency of lipid rich in sphingomyelin are improved, and a higher sphingomyelin enrichment degree is realized in a final product. Meanwhile, ethanol extraction can be directly combined with a freezing crystallization method, other organic solvents are not introduced into the method, the method is green and safe, complex equipment support is not needed, the technological process is short, operation is easy and convenient, cost is low, and the method is suitable for rapid preparation.
Owner:INNER MONGOLIA DAIRY TECH RES INST CO LTD +2

Preparation method of infant formula milk powder capable of simulating breast milk and added with lecithin and MFGM ingredients

The invention discloses a preparation method of breast milk simulating infant formula milk powder added with lecithin and MFGM ingredients, and belongs to the field of infant ingredient powder processing. The preparation method comprises the following steps: (1) analyzing composition of phospholipids from different sources, and selecting egg yolk lecithin compounded with MFGM; and (2) determining the optimal ratio of the added egg yolk lecithin to the MFGM ingredient to be 1: 1. And (3) selecting an optimal process: mixing the MFGM ingredients and egg yolk lecithin with vegetable oil, homogenizing to prepare an emulsion, and finally spraying to prepare the milk powder. According to the research, lecithin and MFGM ingredients are selected to be compounded and added into the infant formula milk powder, so that the fat interface and digestion characteristics can be improved, and the condition that infants become fat due to poor digestion and absorption of lipid is avoided.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Baby formula dispenser with accuracy verification

A baby formula dispensing device is configured to automatically dispense water and powdered baby formula into a bottle and implement various accuracy checks to ensure the prepared mixture is accurate and safe for the baby. A user may input or select a pre-set option for the dispensing device to output a certain amount of formula and water to create the mixture in the bottle. The dispenser device may be filled with formula and water into independent reservoirs or otherwise receive the formula and water. The dispenser automatically measures and dispenses the correct amount of water and formula and dispenses into a bottle. Various sensors are utilized within the dispensing device to ensure the correct amount of formula and water is actually dispensed. Sensors may be placed on the water and formula dispensing circuits and on the scale on which the bottle sits, to perform multiple checks of the bottle's preparation.
Owner:CUDDLETOT LLC

Step-by-step enzymolysis method for alpha-lactalbumin allergic epitopes and application of step-by-step enzymolysis method

The invention discloses a step-by-step enzymolysis method for alpha-lactalbumin allergic epitopes and application, and belongs to the technical field of dairy product processing. Through step-by-step directional enzymolysis of flavourzyme and alpha-chymotrypsin, allergic epitopes in ALA are directionally cleared, and the antigenicity of ALA is remarkably reduced. The method is simple and convenient in process, mild in condition and suitable for large-scale production, and the obtained enzymolysis product can be used for low-sensitization infant formula milk powder and food for special medical purposes and has important application value and social benefits.
Owner:DALIAN POLYTECHNIC UNIVERSITY

Milk fat globule membrane milk protein powder rich in phospholipid as well as preparation method and application of milk fat globule membrane milk protein powder

The invention belongs to the technical field of dairy product processing, and particularly relates to milk fat globule membrane milk protein powder rich in phospholipid as well as a preparation method and application of the milk fat globule membrane milk protein powder. The preparation method of the milk fat globule membrane milk protein powder comprises the following steps: adding chymosin into sweet casein to remove casein so as to obtain casein whey; then sequentially adding whey protein hydrolase and lactase into the casein whey; carrying out ultrafiltration treatment on the hydrolyzed liquid, carrying out percolation treatment on the obtained filtrate, collecting percolate, and drying to obtain a milk fat globule membrane coarse material; and performing CO2 supercritical fluid extraction on the milk fat globule membrane coarse material to obtain the milk fat globule membrane. The phospholipid-rich milk fat globule membrane milk protein powder prepared by the method can be developed into high-polarity lipid food, and especially provides a scientific basis for infant formula milk powder, middle-aged and elderly nutritional food and special functional food.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY +1

Electric heating kettle body (YK-100D)

1. Name of the product in this design: Electric heating kettle body (YK-100D). 2. Purpose of this design: It can be used as a baby formula maker, a kettle, or a herbal tea maker. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the key design points: Design 1 3D view. 5. Design 1 is designated as the basic design.
Owner:GUANGDONG YOUKANG INTELLIGENT TECH CO LTD

Broad-Spectrum Phage for Efficiently Lysing Cronobacter, Bactericide, and Use

Disclosed is a broad-spectrum phage for efficiently lysing Cronobacter, a bactericide, and use thereof. Also provided is a Cronobacter phage vB_CsaM_CBT2, where the phage has a deposit number of CCTCC NO: M 2023524. The phage only specifically lyses Cronobacter, has a broad lysis spectrum, and can cover four species of Cronobacter (including multi-drug-resistant bacteria). The phage shows a desirable stability at a pH value of 3 to 11 and 25° C. to 70° C., and has a bactericidal effect of 80.55% to 99.97% within 12 h in a milk powder sample. Moreover, the phage does not carry any virulence and antibiotic resistance genes, and meets the safety requirements in practical applications. Therefore, the phage provides a new strategy and resource guarantee for the control of Cronobacter contamination in powdered infant formula (PIF) and its industrial chain and environment, as well as the development of bactericides.
Owner:HEFEI UNIV OF TECH

INFANT NUTRITIONAL COMPOSITION FOR USE IN IMPROVING PANCREATIC MATURATION AND INSULIN BIOSYNTHESIS.

This invention relates to nutritional compositions comprising at least one fucosylated oligosaccharide, preferably 2FL, for use in enhancing pancreatic development and / or pancreatic maturation in infants, and / or improving insulin biosynthesis, and / or preventing metabolic disorders or associated diseases, and / or managing glucose during nutritional intervention or later in life. The composition may be an infant formula. The composition may also comprise at least one N-acetylated oligosaccharide, preferably LnNT.
Owner:SOCIETE DES PRODUITS NESTLE SA

Product containers and container assemblies

The present disclosure provides containers and container assemblies for storing and dispensing products, such as infant formula, nutritional and fitness supplements, coffee, sugar, flour, dissolvable cannabinoid, edible cannabis, gummies, flowers, buds, candy, chocolates, baked goods and the like. The containers have a measuring and dispensing device, such as a utensil, removably secured to an internal wall of the container to prevent the utensil from becoming buried within the product. The container may be formed from first and second portions that are molded separately from each other and then joined together, allowing it to be manufactured quickly, easily, and inexpensively.
Owner:KENZINC LLC

Human milk oligosaccharide for improving health of intestinal microenvironment and use thereof

The present disclosure provides human milk oligosaccharide for improving the health of intestinal microenvironment and the use thereof. Specifically, the present disclosure provides the use of human milk oligosaccharide, especially the fucosyl-based oligosaccharide 2′-FL or 3-FL in the preparation of a food for improving the health of the intestinal microenvironment, wherein the improving the health of the intestinal microenvironment includes: functioning as prebiotics in the intestinal system that are used by intestinal flora to produce gas, lowering pH to maintain the health of the intestinal microenvironment, and / or reducing branched chain fatty acids such as isobutyric acid and / or isovaleric acid. The human milk oligosaccharide of the present disclosure is used to be added into infant foods (including infant formula powder, supplementary food, and nutritional supplements), and nutritional supplements or foods for children at the age of 3 years or older, adolescents and adults, and has broad application prospects.
Owner:INNER MONGOLIA YILI IND GROUP CO LTD +1

Compositions containing nicotinamide and vitamin B6 and methods of using such compositions for promoting muscle growth

ActiveUS12661343B2Organic active ingredientsOrganic chemistryVitamin b6Increased muscle function
A composition contains Nicotinamide and Vitamin B6, for example pyridoxine. The composition may be an oral nutritional composition, for example an infant formula, a follow up formula, a nutritional supplement, an oral nutritional supplement, a food product. The composition can be administered to an individual in need thereof for promoting muscle growth and / or for maintaining and / or increasing muscle function and / or muscle mass in infants and children. For example, the composition can be useful for increasing muscle function and / or muscle mass by modulating muscle stem cells.
Owner:SOCIETE DES PRODUITS NESTLE SA

Nutritional composition and infant formula for promoting de novo myelination

A synthetic nutritional composition containing a phospholipid and / or a metabolic precursor and / or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and / or brain structure, and / or brain connectivity, and / or intellectual potential and / or cognitive potential, and / or learning potential and / or cognitive functioning in a subject, in particular a formula fed subject.
Owner:SOCIETE DES PRODUITS NESTLE SA

Infant formula

To provide nutritional compositions, such as infant formulas, that can be used to prevent or reduce the development of allergies in infants.SOLUTION: A baby formula for use in preventing or reducing the incidence of allergic sensitization in babies, wherein the baby formula comprises 0. 8-2. 5g / L 2 ' - fucosyllactose (2 ' FL) and / or 0. 05-0. 2g / L lacto-N-neotetraose (LNnT).SELECTED DRAWING: None
Owner:SOCIETE DES PRODUITS NESTLE SA

Infant formula preparation apparatus and method

ActiveUS12672735B2FormularyAnimal science
An infant formula dispensing apparatus has a receptacle for receiving a sealed pod containing an amount of infant formula powder sufficient for a single feeding of a predetermined size. When the pod is placed in the receptacle, a fixture of the apparatus pierces the pod and forces warm water through the pod. The water mixes with the infant formula powder in the pod and exits the pod though a spout, where it is received in a receptacle, such as a lidless baby bottle.
Owner:ROBERSON DANNY J +2

Infant formula

An infant formula for use in preventing or reducing the occurrence of allergic sensitisation in an infant, wherein the infant formula comprises 0.8-2.5 g / L 2′-fucosyllactose (2′FL) and / or 0.05-0.2 g / L lacto-N-neotetraose (LNnT).
Owner:SOCIETE DES PRODUITS NESTLE SA

Composition for relieving visual fatigue and application thereof

The invention belongs to the technical field of microbial engineering, and discloses a composition for relieving visual fatigue and application thereof.The composition comprises bifidobacterium longum subsp. Infantis i18, 2 '-fucosyllactose and lactose-N-neotetraose, all the components of the composition are synergistic, eye cell apoptosis can be improved, and the purpose of relieving visual fatigue is achieved; the invention also provides application of the composition for relieving visual fatigue in preparing infant formula milk powder, child formula milk powder or health food with the effect of relieving visual fatigue.
Owner:JUNLEBAO DAIRY GRP CO LTD